Marks Jessica, Saifudeen Zubaida, Dipp Susana, El-Dahr Samir S
Department of Pediatrics, Section of Pediatric Nephrology, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USA.
J Biol Chem. 2003 Sep 5;278(36):34158-66. doi: 10.1074/jbc.M304543200. Epub 2003 Jun 5.
Although p53 is known to have dual functions as a transcriptional activator and repressor, there has not been an example where both p53-activating and -repressing elements reside within one target promoter. Previous work from this laboratory defined two different p53 response elements, termed P1 and P2, located at nucleotide positions -70 and -707, respectively, in the rat bradykinin B2 receptor promoter. In this study, through manipulation of the DNA sequence and context, we demonstrate opposing roles for P1 and P2 as transcriptional activator and repressor, respectively. Deletion of P1 abrogates p53-mediated activation. P1 maintains its role as an activator upon relocation to the P2 site and activates transcription from a heterologous promoter construct. Thus, P1 is a bona fide positive p53-response element. In contrast, deletion of P2 enhances P1-induced activation. P2 represses transcription when substituted for P1 or when relocated midway between P1 and P2. P2-mediated repression is sequence-dependent, because it is reversed to activation when P2 is substituted by the P1 or p53 consensus sequences. Moreover, site-directed mutagenesis that converts P2 to a higher affinity p53-binding site results in transcriptional activation rather than repression. Surprisingly, P2 strongly activates a heterologous promoter. Thus, P2-mediated transcriptional repression is both sequence- and context-dependent. Investigations into the mechanisms of P2-mediated repression indicate that it is trichostatin-insensitive and unaffected by CBP or mutation of the minimal repression C-terminal domain of p53. However, gel shift assays suggest that p53 competes with other transcriptional activators for binding to overlapping binding sequences within the P2 element. In conclusion, this study provides a rare example of a transcription factor having two divergent functional effects that are sequence- and context-dependent. The interplay of P1 and P2 may be important in the regulation of bradykinin B2 receptor gene expression in response to inflammatory stress and during development.
尽管已知p53具有转录激活因子和转录抑制因子的双重功能,但尚未有一个例子表明p53激活元件和抑制元件同时存在于一个靶启动子中。本实验室之前的工作在大鼠缓激肽B2受体启动子中定义了两个不同的p53反应元件,分别称为P1和P2,位于核苷酸位置-70和-707。在本研究中,通过对DNA序列和背景的操作,我们分别证明了P1和P2作为转录激活因子和转录抑制因子的相反作用。删除P1可消除p53介导的激活作用。P1重新定位到P2位点后仍保持其激活因子的作用,并激活来自异源启动子构建体的转录。因此,P1是一个真正的正向p53反应元件。相反,删除P2可增强P1诱导的激活作用。当P2替代P1或重新定位到P1和P2之间的中间位置时,P2会抑制转录。P2介导的抑制作用是序列依赖性的,因为当P2被P1或p53共有序列替代时,它会转变为激活作用。此外,将P2转化为更高亲和力的p53结合位点的定点诱变会导致转录激活而非抑制。令人惊讶的是,P2强烈激活异源启动子。因此,P2介导的转录抑制作用是序列和背景依赖性的。对P2介导的抑制机制的研究表明,它对曲古抑菌素不敏感,不受CBP或p53最小抑制性C末端结构域突变的影响。然而,凝胶迁移试验表明,p53与其他转录激活因子竞争结合P2元件内的重叠结合序列。总之,本研究提供了一个罕见的例子,即转录因子具有两种不同的功能效应,且这些效应是序列和背景依赖性的。P1和P2之间的相互作用可能在炎症应激反应和发育过程中缓激肽B2受体基因表达的调节中起重要作用。